Yale SPORE in Skin Cancer Project 2
Demographics (4)
- AGE - Subject age at enrollment (phv00481447.v2.p1)
- COLLECTION_AGE - Age sample was collected (phv00481454.v2.p1)
- SEX - Biological sex (phv00481446.v2.p1)
- SEX - Biological sex (phv00481441.v2.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00481448.v2.p1)
Other (23)
- ANALYTE_TYPE - Analyte Type (phv00481451.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00481450.v2.p1)
- cdr3_nt_TRA - Nucleotide sequence of the TCR alpha chain CDR3 (phv00481463.v2.p1)
- cdr3_nt_TRB - Nucleotide sequence of the TCR beta chain CDR3 (phv00481464.v2.p1)
- cdr3_TRA - Aminoacid sequence of the TCR alpha chain CDR3 (phv00481461.v2.p1)
- cdr3_TRB - Aminoacid sequence of the TCR beta chain CDR3 (phv00481462.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00481440.v2.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00481453.v2.p1)
- IS_TUMOR - Tumor status (phv00481452.v2.p1)
- Organ - Organ from where the T cells where harvested (phv00481466.v2.p1)
- POOLED_SAMPLE_ID - Sample-level ID (phv00481467.v2.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00481455.v2.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00481456.v2.p1)
- SAMPLE_ID - Sample-level ID (phv00481449.v2.p1)
- SAMPLE_ID - Cell-level ID (phv00481459.v2.p1)
- SAMPLE_ID - Cell-level ID (phv00481443.v2.p1)
- Seqbatch - Sequencing batch serial number (phv00481465.v2.p1)
- SUBJECT_ID - Subject ID (phv00481460.v2.p1)
- SUBJECT_ID - Subject ID (phv00481445.v2.p1)
- SUBJECT_ID - Subject ID (phv00481439.v2.p1)
- SUBJECT_ID - Subject ID (phv00481442.v2.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00481457.v2.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00481458.v2.p1)